News

News

VAIM and VAIM GLOBAL Merge to Strengthen Global Aesthetic Leadership

Author
Ju**************
Date
2025-04-01 17:22
Views
163


VAIM and VAIM GLOBAL Merge to Strengthen Global Aesthetic Leadership

VAIM and VAIM GLOBAL Merge to Strengthen Global Aesthetic Leadership

April 1, 2025 – VAIM and VAIM GLOBAL have officially merged, marking a transformative step in their mission to lead the global aesthetic industry. This strategic move enhances their competitive edge and solidifies their position in the global market.

For years, VAIM has specialized in product manufacturing, quality innovation, and technological development, while VAIM GLOBAL has focused on strategic planning, marketing, and domestic and international sales, driving global expansion. Though previously operating as separate entities, the two companies have now united to streamline collaboration and maximize operational efficiency.

This merger strengthens the core expertise of both companies, positioning the new VAIM with a stronger competitive advantage in the rapidly evolving aesthetic industry.

A VAIM representative stated, “We remain committed to delivering safer, more innovative products. We sincerely appreciate your continued support and look forward to the exciting opportunities ahead.”

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.